The online versions of legislation provided on this website are not official. Enrolled bills are the final version passed by the Ohio General Assembly and presented to the Governor for signature. The official version of acts signed by the Governor are available from the Secretary of State's Office in the Continental Plaza, 180 East Broad St., Columbus.
|
S. C. R. No. 40 As IntroducedAs Introduced 130th General Assembly | Regular Session | 2013-2014 |
| |
Cosponsors:
Senators Cafaro, Balderson, Turner, Schiavoni, Kearney
A CONCURRENT RESOLUTION | To urge the Congress of the United States to mitigate
the debilitative effects of type 1 diabetes and
excessive future health care costs by increasing
funding to the National Institutes of Health for
research to promote the widespread and affordable
availability of a closed-loop diabetic system,
referred to as the "artificial pancreas," and
islet cell transplantation.
|
BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO (THE HOUSE OF REPRESENTATIVES CONCURRING):
WHEREAS, More than one million Americans have been diagnosed
with insulin-dependent diabetes mellitus, otherwise known as type
1 diabetes; and |
WHEREAS, Type 1 diabetes is a disease that frequently strikes
children suddenly, makes them insulin dependent for life, and
carries the constant threat of life-threatening complications; and |
WHEREAS, The number of diagnoses of type 1 diabetes is
growing at an alarming rate; and |
WHEREAS, The cost of type 1 diabetes, including medical
expenses and lost productivity, is billions of dollars per year;
and |
WHEREAS, Type 1 diabetes is a leading cause of blindness,
kidney failure, amputations, heart disease, and death; and |
WHEREAS, Medical and technological advances in the
development of the closed-loop insulin delivery system and islet
cell transplantation have created meaningful and realistic
pathways to a cure of type 1 diabetes; and |
WHEREAS, Adequate funding for research and development of the
closed-loop system and islet cell transplantation will result in
positive medical outcomes for millions of Americans who are
affected by type 1 diabetes and thereby ameliorate widespread
human suffering and preserve billions of dollars in tax payer
funds; and |
WHEREAS, Current levels of NIH funding designated for
advancing the technology associated with the closed-loop system
and islet cell transplantation are inadequate and an increase in
funding will expedite the refining of and access to these
important medical technologies; now therefore be it |
RESOLVED, That we, the members of the 130th General Assembly
of the State of Ohio, in adopting this resolution, urge the
Congress of the United States to increase funding levels for
research and development of the closed-loop system and islet cell
transplantation so that those suffering from type 1 diabetes will
have expedited access to such technology, thus enhancing health
care while saving billions of dollars in health care costs and
lost productivity; and be it further |
RESOLVED, That the Clerk of the Senate transmit duly
authenticated copies of this resolution to the President Pro
Tempore and Secretary of the United States Senate, the Speaker and
Clerk of the United States House of Representatives, and each
member of the Ohio Congressional delegation. |
|
|